Addition of oxaliplatin to continuous fluorouracil, L-folinic acid, and concomitant radiotherapy in rectal cancer: The Lyon R 97-03 phase I trial

Journal of Clinical Oncology

Volumn 19, Issue 9, 2001, Pages 2433-2438

  Freyer, G ^a   Bossard, N ^a   Romestaing, P ^a   Mornex, F ^a   Chapet, O ^a   Trillet Lenoir, V ^a   Gerard J P ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; AGED; ARTICLE; ASTHENIA; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DYSESTHESIA; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; MALE; MAXIMUM TOLERATED DOSE; METASTASIS; NEUROTOXICITY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RECTUM CANCER; THROMBOCYTOPENIA; VOMITING; WEIGHT REDUCTION;

EID: 0035340318     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.9.2433     Document Type: Article

References (22)

1. Short term preoperative radiotherapy for colorectal cancer
2. Pre or post operative radiotherapy in rectal and rectosigmoid carcinoma
3. Pre operative radiotherapy in Duke's B and C carcinoma of the rectum and rectosigmoid: A randomized multicenter study
4. Influence of the interval between preoperative radiation therapy and surgery on downstaging and the rate of sphincter-sparing surgery for rectal cancer: The Lyon R90-01 randomized trial
5. Effective surgical adjuvant therapy for high risk rectal cancer
6. Improving adjuvant therapy for rectal cancer by combining protracted infusion fluorouracil with radiation therapy after curative surgery
7. Randomized controlled trial of postoperative radiotherapy and short terra rime scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer
8. Preoperative radiochemotherapy in rectal cancer: Long-term results of a phase II trial
9. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: A French intergroup study
10. Clinical efficacy of oxaliplatin monotherapy: Phase II trials in advanced colorectal cancer
11. Leucovorin and fluorouracil without oxaliplatin as first-line treatment in advanced colorectal cancer
12. Oxaliplatin: In vitro and in vivo evidence of its radiation sensitizing activity
13. Endocavitary radiation therapy
14. Combined curative radiation therapy alone in (TI) T2-3 rectal adenocarcinoma: A pilot study of 29 patients
15. A phase I trial of trans-1-diaminocyclohexane oxalato-platinum (LOHP)
16. Phase I study of oxaliplatin in patients with advanced cancer
17. Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant toprevious treatment with fluoropyrimidines
18. Choice of starting dose and escalation for phase I studies of antitumor agents
19. Design and analysis of phase I clinical trials
20. Design and results of phase I cancer clinical trials: Three-year experience ar the MD Anderson Cancer Center
21. Investigation of the comparative toxicity of the 5-FU bolus versus 5-FU continuous infusion circadian chemotherapy with concurrent radiation therapy in locally advanced rectal cancer
22. Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer